Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($)	9 Months Ended
	Sep. 30, 2022	Sep. 30, 2021
Cash flows from operating activities:
Net loss	$ (1,150,629)	$ (1,303,191)
Adjustments to reconcile net loss to net cash used in operating activities:
Change in fair value of notes payable in gold	(35,777)	(38,631)
Accretion of asset retirement obligation	5,060	4,866
Gain on forgiveness of CARES Act PPP loan		(51,135)
Amortization of discount on notes payable – related party	4,420	14,657
Change in:
Prepaid expenses	65,371	39,435
Accounts payable and accrued liabilities	63,815	(3,928)
Interest payable	174,557	169,250
Interest payable – related party	462,814	421,982
Related party payable	161,658	193,221
Net cash used - operating activities	(248,711)	(553,474)
Cash flows from financing activities:
Proceeds from warrant exercises	133,157	223,749
Proceeds on subscription payable	30,000	49,700
Proceeds from notes payable		25,000
Proceeds from notes payable– related party	83,980	253,500
Net cash provided - financing activities	247,137	551,949
Net change in cash and cash equivalents	(1,574)	(1,525)
Cash and cash equivalents, beginning of period	3,762	1,931
Cash and cash equivalents, end of period	2,188	406
Non-cash Investing and Financing Activities:
Common stock issued for interest payable		4,212
Common shares issued for conversion of series D preferred stock	$ 200,000